Innovative Industrial Properties IIPR stock analysis And what to expect next with IIPR stock

Risk adjusted net present value: What is the current valuation of Aquestive Therapeutics’s Epinephrine?

Epinephrine is a small molecule commercialized by Aquestive Therapeutics, with a leading Phase III program in Anaphylaxis.

December 14, 2024

High Tide Q2 Revenue Flat to Q1 at C$118.1 Million

High Tide Reports Third Consecutive Quarter of Record Revenue and Adjusted EBITDA of $118.1 Million and $6.6 Million, Respectively The Company Achieved Significant Sequential Improvement

June 15, 2023

AI tool could revolutionize placenta examination and improve neonatal care

A newly developed tool that harnesses computer vision and artificial intelligence (AI) may help clinicians rapidly evaluate placentas at birth, potentially improving neonatal and maternal

December 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.